A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2011
11/02/2011	CN102228547A Application of traditional Chinese medicine composition in preparing medicaments treating pancreatitis and/or cholecystitis
11/02/2011	CN102228545A Medicament for treating peptic ulcer
11/02/2011	CN102228531A Chinese medicinal composition for treating dental ulcers
11/02/2011	CN102228530A Capsule for treating ulcerative colitis
11/02/2011	CN102228523A Preparation method of total diterpenoid alkaloids from Delphinium Staphisagria
11/02/2011	CN102228518A Chinese medicinal decoction for treating white scour of piglets and preparation method thereof
11/02/2011	CN102228484A Chinese medicinal preparation Jinshuibao oral liquid and preparation method thereof
11/02/2011	CN102228481A Propolis injection for preventing type I duck virus hepatitis and preparation method thereof
11/02/2011	CN102228479A Medicine for treating oral diseases and preparation method thereof
11/02/2011	CN102228477A Application of starfish extract to preparation of medicament for treating digestive system diseases
11/02/2011	CN102228475A Stem cell compound medicament for preventing and/or treating cirrhosis and preparation method thereof
11/02/2011	CN102228464A Tenofovir composition
11/02/2011	CN102228463A Tenofovir crystals
11/02/2011	CN102228462A Method for preparing veterinary oxytetracycline-artemisinin injection and clinical application of veterinary oxytetracycline-artemisinin injection
11/02/2011	CN102228446A Alprostadil lipid nanosphere freeze-drying injection and preparation method thereof
11/02/2011	CN102228445A Freeze-dried powder of ectoine or ectoine derivative for injection
11/02/2011	CN102228179A Fructose sodium diphosphate oral solution and preparation method thereof
11/02/2011	CN101999990B Anti-caries and antiallergic mouth wash
11/02/2011	CN101983701B Traditional Chinese medicine compound preparation with protective effects on stomach and intestines
11/02/2011	CN101972443B Chinese medicinal formula for treating chronic gastritis
11/02/2011	CN101940664B Chinese materia medica preparation for tonifying kidney and spleen
11/02/2011	CN101870701B Bergenin isopentene group derivative and preparation method and application thereof
11/02/2011	CN101850044B Medicament for treating peptic ulcer and reflux esophagitis and preparation method thereof
11/02/2011	CN101732664B Enprostil-containing Chinese and Western medicinal composition for treating gastric ulcer
11/02/2011	CN101732663B Rebamipide-containing Chinese and western medicinal composition
11/02/2011	CN101732492B Adinandra nitida leaf flavone oral tablet and preparation method
11/02/2011	CN101721451B Synergistic medicinal composition
11/02/2011	CN101647844B Vinegar milk essence micro effervescent granules and preparation method thereof
11/02/2011	CN101607086B Compound bismuth composition and preparation method thereof
11/02/2011	CN101574397B WuRenChun self-emulsifying soft capsule preparation and preparation method
11/02/2011	CN101401926B Umbilicus-applied medicament for treating emesis of chemotherapy
11/02/2011	CN101190263B Rhubarb chewable tablets and preparation method and application thereof
11/02/2011	CN101167843B 'Preparation method of yinzhihuang' injection
11/02/2011	CN101160306B Benzimidazole compound
11/02/2011	CN101125160B Method for preparing preparation for treating gastroenteritis and its new use
11/02/2011	CN101108219B Method of preparing traditional Chinese medicine formulated product for treating gastroenteritis
11/02/2011	CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048909 Proton pump inhibitors
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	CA2671949C Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
11/01/2011	CA2657550C Benzimidazole derivatives as selective acid pump inhibitors
11/01/2011	CA2490254C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
11/01/2011	CA2473591C 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
11/01/2011	CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011	CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011	CA2466418C Lipoxin a4 analogs
11/01/2011	CA2461662C Method and tools for oral hygiene
11/01/2011	CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases
11/01/2011	CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011	CA2434526C Methods of administering epothilone analogs for the treatment of cancer
11/01/2011	CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
11/01/2011	CA2395459C Use of quinoline and quinolizinone derivatives as chemotherapeutic agents
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
10/2011
10/27/2011	WO2011133897A2 Methods and materials for reducing liver fibrosis
10/27/2011	WO2011133887A2 Prevention and treatment of gastrointestinal infection in mammals
10/27/2011	WO2011133600A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
10/27/2011	WO2011133596A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives
10/27/2011	WO2011133180A1 Chemosensory receptor ligand-based therapies
10/27/2011	WO2011132943A2 Composition for treatment of acute pseudomembranous colitis
10/27/2011	WO2011132085A2 Methods and compositions for treating fibrosis
10/27/2011	WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011	WO2011130817A1 Pharmaceutical formulation and method for reducing hepatotoxicity
10/27/2011	WO2011087769A3 Nutritional compositions and methods for optimizing dietary acid-base potential
10/27/2011	WO2011087713A3 Substituted hexahydrochromeno [3, 4 - b] pyrroles with affinity for the serotonin receptor (5-ht) family
10/27/2011	WO2011047350A3 Emesis treatment
10/27/2011	US20110263721 Aryl di-substituted propenone compounds
10/27/2011	US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011	US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011	US20110263661 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
10/27/2011	US20110263659 Analogs of 1-Methylnicotinamide
10/27/2011	US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011	US20110263628 N-hydroxyamide derivatives and use thereof
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263605 Azabicyclo[2.2.1]Heptane Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands
10/27/2011	US20110263601 Methods of treating ulcerative colitis
10/27/2011	US20110263595 Compounds and methods for kinase modulation, and indications therefor
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263588 Tricyclic compounds as glutamate receptor modulators
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110263578 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011	US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011	US20110263575 Compounds Useful as Protein Kinase Inhibitors
10/27/2011	US20110263573 Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
10/27/2011	US20110263571 Novel amide derivative and use thereof as medicine
10/27/2011	US20110263568 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
10/27/2011	US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011	US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011	US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011	US20110263547 C-19 steroids for specific therapeutic uses
10/27/2011	US20110263546 Polyhydroxylated Bile Acids for Treatment of Biliary Disorders
10/27/2011	US20110263531 Methods for the treatment and amelioration of atopic dermatitis
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011	US20110263495 Methods and kits for treating disease by administering insulin-like growth factor binding protein-2
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263027 Adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby

1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 1258